nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A5—Irinotecan—colon cancer	0.122	0.283	CbGbCtD
Oxybutynin—CYP2C8—Fluorouracil—colon cancer	0.113	0.262	CbGbCtD
Oxybutynin—CYP3A5—Vincristine—colon cancer	0.107	0.248	CbGbCtD
Oxybutynin—CYP3A4—Irinotecan—colon cancer	0.0476	0.111	CbGbCtD
Oxybutynin—CYP3A4—Vincristine—colon cancer	0.0416	0.0966	CbGbCtD
Oxybutynin—CHRM3—ureter—colon cancer	0.0369	0.378	CbGeAlD
Oxybutynin—CHRM3—muscle of abdomen—colon cancer	0.0266	0.272	CbGeAlD
Oxybutynin—CHRM5—epithelium—colon cancer	0.00566	0.0579	CbGeAlD
Oxybutynin—CHRM3—smooth muscle tissue—colon cancer	0.00305	0.0312	CbGeAlD
Oxybutynin—CHRM3—renal system—colon cancer	0.00294	0.0301	CbGeAlD
Oxybutynin—CHRM3—digestive system—colon cancer	0.00241	0.0246	CbGeAlD
Oxybutynin—CYP2C8—renal system—colon cancer	0.00238	0.0244	CbGeAlD
Oxybutynin—CYP3A5—renal system—colon cancer	0.00215	0.022	CbGeAlD
Oxybutynin—CYP3A5—digestive system—colon cancer	0.00176	0.018	CbGeAlD
Oxybutynin—CYP2C8—vagina—colon cancer	0.00173	0.0177	CbGeAlD
Oxybutynin—CYP3A4—renal system—colon cancer	0.00161	0.0165	CbGeAlD
Oxybutynin—CYP2D6—renal system—colon cancer	0.00159	0.0163	CbGeAlD
Oxybutynin—CYP3A5—vagina—colon cancer	0.00156	0.0159	CbGeAlD
Oxybutynin—CYP2C8—liver—colon cancer	0.00146	0.0149	CbGeAlD
Oxybutynin—CYP3A4—digestive system—colon cancer	0.00132	0.0135	CbGeAlD
Oxybutynin—CYP3A5—liver—colon cancer	0.00131	0.0134	CbGeAlD
Oxybutynin—CYP2D6—digestive system—colon cancer	0.0013	0.0133	CbGeAlD
Oxybutynin—Back pain—Irinotecan—colon cancer	0.0012	0.00254	CcSEcCtD
Oxybutynin—Abdominal distension—Capecitabine—colon cancer	0.0012	0.00254	CcSEcCtD
Oxybutynin—Influenza—Capecitabine—colon cancer	0.00119	0.00253	CcSEcCtD
Oxybutynin—Asthma—Capecitabine—colon cancer	0.00119	0.00253	CcSEcCtD
Oxybutynin—Dysphagia—Capecitabine—colon cancer	0.00119	0.00253	CcSEcCtD
Oxybutynin—Erythema—Fluorouracil—colon cancer	0.00119	0.00252	CcSEcCtD
Oxybutynin—Agitation—Vincristine—colon cancer	0.00117	0.00248	CcSEcCtD
Oxybutynin—Ill-defined disorder—Irinotecan—colon cancer	0.00115	0.00244	CcSEcCtD
Oxybutynin—Bronchitis—Capecitabine—colon cancer	0.00115	0.00243	CcSEcCtD
Oxybutynin—Abdominal discomfort—Capecitabine—colon cancer	0.00114	0.00242	CcSEcCtD
Oxybutynin—Vision blurred—Fluorouracil—colon cancer	0.00112	0.00237	CcSEcCtD
Oxybutynin—Malaise—Irinotecan—colon cancer	0.00112	0.00237	CcSEcCtD
Oxybutynin—Dysuria—Capecitabine—colon cancer	0.00111	0.00236	CcSEcCtD
Oxybutynin—Syncope—Irinotecan—colon cancer	0.00111	0.00236	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Capecitabine—colon cancer	0.00111	0.00235	CcSEcCtD
Oxybutynin—Convulsion—Vincristine—colon cancer	0.0011	0.00234	CcSEcCtD
Oxybutynin—Hypertension—Vincristine—colon cancer	0.0011	0.00233	CcSEcCtD
Oxybutynin—Loss of consciousness—Irinotecan—colon cancer	0.00109	0.00231	CcSEcCtD
Oxybutynin—Cough—Irinotecan—colon cancer	0.00108	0.0023	CcSEcCtD
Oxybutynin—Hypertension—Irinotecan—colon cancer	0.00107	0.00227	CcSEcCtD
Oxybutynin—Infestation NOS—Capecitabine—colon cancer	0.00106	0.00225	CcSEcCtD
Oxybutynin—Infestation—Capecitabine—colon cancer	0.00106	0.00225	CcSEcCtD
Oxybutynin—Depression—Capecitabine—colon cancer	0.00106	0.00225	CcSEcCtD
Oxybutynin—Discomfort—Irinotecan—colon cancer	0.00104	0.00221	CcSEcCtD
Oxybutynin—Anaphylactic shock—Vincristine—colon cancer	0.00104	0.0022	CcSEcCtD
Oxybutynin—Oedema—Vincristine—colon cancer	0.00104	0.0022	CcSEcCtD
Oxybutynin—Stomatitis—Capecitabine—colon cancer	0.00104	0.0022	CcSEcCtD
Oxybutynin—Infection—Vincristine—colon cancer	0.00103	0.00219	CcSEcCtD
Oxybutynin—Urinary tract infection—Capecitabine—colon cancer	0.00103	0.00219	CcSEcCtD
Oxybutynin—Conjunctivitis—Capecitabine—colon cancer	0.00103	0.00219	CcSEcCtD
Oxybutynin—Convulsion—Fluorouracil—colon cancer	0.00103	0.00218	CcSEcCtD
Oxybutynin—Osteoarthritis—Methotrexate—colon cancer	0.00103	0.00218	CcSEcCtD
Oxybutynin—Confusional state—Irinotecan—colon cancer	0.00102	0.00216	CcSEcCtD
Oxybutynin—Nervous system disorder—Vincristine—colon cancer	0.00102	0.00216	CcSEcCtD
Oxybutynin—Haematuria—Capecitabine—colon cancer	0.00101	0.00215	CcSEcCtD
Oxybutynin—Anaphylactic shock—Irinotecan—colon cancer	0.00101	0.00215	CcSEcCtD
Oxybutynin—Oedema—Irinotecan—colon cancer	0.00101	0.00215	CcSEcCtD
Oxybutynin—Chest pain—Fluorouracil—colon cancer	0.00101	0.00214	CcSEcCtD
Oxybutynin—Infection—Irinotecan—colon cancer	0.00101	0.00213	CcSEcCtD
Oxybutynin—Epistaxis—Capecitabine—colon cancer	0.001	0.00212	CcSEcCtD
Oxybutynin—Discomfort—Fluorouracil—colon cancer	0.000999	0.00212	CcSEcCtD
Oxybutynin—Shock—Irinotecan—colon cancer	0.000996	0.00211	CcSEcCtD
Oxybutynin—Nervous system disorder—Irinotecan—colon cancer	0.000993	0.00211	CcSEcCtD
Oxybutynin—Anorexia—Vincristine—colon cancer	0.000991	0.0021	CcSEcCtD
Oxybutynin—CYP3A4—liver—colon cancer	0.000986	0.0101	CbGeAlD
Oxybutynin—Confusional state—Fluorouracil—colon cancer	0.000977	0.00207	CcSEcCtD
Oxybutynin—Mood swings—Methotrexate—colon cancer	0.000972	0.00206	CcSEcCtD
Oxybutynin—Hypotension—Vincristine—colon cancer	0.000971	0.00206	CcSEcCtD
Oxybutynin—CYP2D6—liver—colon cancer	0.00097	0.00993	CbGeAlD
Oxybutynin—Oedema—Fluorouracil—colon cancer	0.000969	0.00206	CcSEcCtD
Oxybutynin—Anaphylactic shock—Fluorouracil—colon cancer	0.000969	0.00206	CcSEcCtD
Oxybutynin—Anorexia—Irinotecan—colon cancer	0.000965	0.00205	CcSEcCtD
Oxybutynin—Infection—Fluorouracil—colon cancer	0.000963	0.00204	CcSEcCtD
Oxybutynin—Rhinitis—Capecitabine—colon cancer	0.000956	0.00203	CcSEcCtD
Oxybutynin—Nervous system disorder—Fluorouracil—colon cancer	0.000951	0.00202	CcSEcCtD
Oxybutynin—Hypoaesthesia—Capecitabine—colon cancer	0.000949	0.00201	CcSEcCtD
Oxybutynin—Liver function test abnormal—Methotrexate—colon cancer	0.000947	0.00201	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000947	0.00201	CcSEcCtD
Oxybutynin—Pharyngitis—Capecitabine—colon cancer	0.000946	0.00201	CcSEcCtD
Oxybutynin—Tachycardia—Fluorouracil—colon cancer	0.000946	0.00201	CcSEcCtD
Oxybutynin—Hypotension—Irinotecan—colon cancer	0.000946	0.00201	CcSEcCtD
Oxybutynin—Urinary tract disorder—Capecitabine—colon cancer	0.000942	0.002	CcSEcCtD
Oxybutynin—Insomnia—Vincristine—colon cancer	0.00094	0.00199	CcSEcCtD
Oxybutynin—Oedema peripheral—Capecitabine—colon cancer	0.000939	0.00199	CcSEcCtD
Oxybutynin—Connective tissue disorder—Capecitabine—colon cancer	0.000937	0.00199	CcSEcCtD
Oxybutynin—Urethral disorder—Capecitabine—colon cancer	0.000935	0.00198	CcSEcCtD
Oxybutynin—Paraesthesia—Vincristine—colon cancer	0.000933	0.00198	CcSEcCtD
Oxybutynin—Breast disorder—Methotrexate—colon cancer	0.000927	0.00197	CcSEcCtD
Oxybutynin—Anorexia—Fluorouracil—colon cancer	0.000924	0.00196	CcSEcCtD
Oxybutynin—Visual impairment—Capecitabine—colon cancer	0.000919	0.00195	CcSEcCtD
Oxybutynin—Insomnia—Irinotecan—colon cancer	0.000915	0.00194	CcSEcCtD
Oxybutynin—Paraesthesia—Irinotecan—colon cancer	0.000909	0.00193	CcSEcCtD
Oxybutynin—Hypotension—Fluorouracil—colon cancer	0.000906	0.00192	CcSEcCtD
Oxybutynin—Decreased appetite—Vincristine—colon cancer	0.000903	0.00192	CcSEcCtD
Oxybutynin—Somnolence—Irinotecan—colon cancer	0.0009	0.00191	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Vincristine—colon cancer	0.000897	0.0019	CcSEcCtD
Oxybutynin—Fatigue—Vincristine—colon cancer	0.000896	0.0019	CcSEcCtD
Oxybutynin—Eye disorder—Capecitabine—colon cancer	0.000891	0.00189	CcSEcCtD
Oxybutynin—Dyspepsia—Irinotecan—colon cancer	0.000891	0.00189	CcSEcCtD
Oxybutynin—Tinnitus—Capecitabine—colon cancer	0.000889	0.00189	CcSEcCtD
Oxybutynin—Pain—Vincristine—colon cancer	0.000889	0.00189	CcSEcCtD
Oxybutynin—Constipation—Vincristine—colon cancer	0.000889	0.00189	CcSEcCtD
Oxybutynin—Asthma—Methotrexate—colon cancer	0.000887	0.00188	CcSEcCtD
Oxybutynin—Flushing—Capecitabine—colon cancer	0.000885	0.00188	CcSEcCtD
Oxybutynin—Cardiac disorder—Capecitabine—colon cancer	0.000885	0.00188	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000883	0.00187	CcSEcCtD
Oxybutynin—Decreased appetite—Irinotecan—colon cancer	0.00088	0.00187	CcSEcCtD
Oxybutynin—Insomnia—Fluorouracil—colon cancer	0.000877	0.00186	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000874	0.00185	CcSEcCtD
Oxybutynin—Fatigue—Irinotecan—colon cancer	0.000873	0.00185	CcSEcCtD
Oxybutynin—Paraesthesia—Fluorouracil—colon cancer	0.00087	0.00185	CcSEcCtD
Oxybutynin—Pain—Irinotecan—colon cancer	0.000865	0.00184	CcSEcCtD
Oxybutynin—Constipation—Irinotecan—colon cancer	0.000865	0.00184	CcSEcCtD
Oxybutynin—Angiopathy—Capecitabine—colon cancer	0.000865	0.00183	CcSEcCtD
Oxybutynin—Somnolence—Fluorouracil—colon cancer	0.000862	0.00183	CcSEcCtD
Oxybutynin—Mediastinal disorder—Capecitabine—colon cancer	0.000859	0.00182	CcSEcCtD
Oxybutynin—Dyspepsia—Fluorouracil—colon cancer	0.000853	0.00181	CcSEcCtD
Oxybutynin—Arrhythmia—Capecitabine—colon cancer	0.000852	0.00181	CcSEcCtD
Oxybutynin—Abdominal discomfort—Methotrexate—colon cancer	0.00085	0.0018	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Vincristine—colon cancer	0.00085	0.0018	CcSEcCtD
Oxybutynin—Decreased appetite—Fluorouracil—colon cancer	0.000843	0.00179	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000837	0.00178	CcSEcCtD
Oxybutynin—Mental disorder—Capecitabine—colon cancer	0.000835	0.00177	CcSEcCtD
Oxybutynin—Feeling abnormal—Irinotecan—colon cancer	0.000834	0.00177	CcSEcCtD
Oxybutynin—Erythema—Capecitabine—colon cancer	0.00083	0.00176	CcSEcCtD
Oxybutynin—Malnutrition—Capecitabine—colon cancer	0.00083	0.00176	CcSEcCtD
Oxybutynin—Dysuria—Methotrexate—colon cancer	0.000829	0.00176	CcSEcCtD
Oxybutynin—Pain—Fluorouracil—colon cancer	0.000829	0.00176	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Irinotecan—colon cancer	0.000828	0.00176	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Methotrexate—colon cancer	0.000824	0.00175	CcSEcCtD
Oxybutynin—Abdominal pain—Vincristine—colon cancer	0.000822	0.00174	CcSEcCtD
Oxybutynin—Flatulence—Capecitabine—colon cancer	0.000818	0.00173	CcSEcCtD
Oxybutynin—Erectile dysfunction—Methotrexate—colon cancer	0.000817	0.00173	CcSEcCtD
Oxybutynin—Dysgeusia—Capecitabine—colon cancer	0.000813	0.00172	CcSEcCtD
Oxybutynin—Back pain—Capecitabine—colon cancer	0.000803	0.0017	CcSEcCtD
Oxybutynin—Abdominal pain—Irinotecan—colon cancer	0.0008	0.0017	CcSEcCtD
Oxybutynin—Feeling abnormal—Fluorouracil—colon cancer	0.000799	0.00169	CcSEcCtD
Oxybutynin—Infestation—Methotrexate—colon cancer	0.000791	0.00168	CcSEcCtD
Oxybutynin—Infestation NOS—Methotrexate—colon cancer	0.000791	0.00168	CcSEcCtD
Oxybutynin—Drowsiness—Methotrexate—colon cancer	0.000791	0.00168	CcSEcCtD
Oxybutynin—Depression—Methotrexate—colon cancer	0.000788	0.00167	CcSEcCtD
Oxybutynin—Vision blurred—Capecitabine—colon cancer	0.000782	0.00166	CcSEcCtD
Oxybutynin—Stomatitis—Methotrexate—colon cancer	0.000771	0.00163	CcSEcCtD
Oxybutynin—Ill-defined disorder—Capecitabine—colon cancer	0.00077	0.00163	CcSEcCtD
Oxybutynin—Urticaria—Fluorouracil—colon cancer	0.00077	0.00163	CcSEcCtD
Oxybutynin—Conjunctivitis—Methotrexate—colon cancer	0.000769	0.00163	CcSEcCtD
Oxybutynin—Hypersensitivity—Vincristine—colon cancer	0.000766	0.00162	CcSEcCtD
Oxybutynin—Haematuria—Methotrexate—colon cancer	0.000754	0.0016	CcSEcCtD
Oxybutynin—Malaise—Capecitabine—colon cancer	0.000748	0.00159	CcSEcCtD
Oxybutynin—Epistaxis—Methotrexate—colon cancer	0.000746	0.00158	CcSEcCtD
Oxybutynin—Hypersensitivity—Irinotecan—colon cancer	0.000746	0.00158	CcSEcCtD
Oxybutynin—Asthenia—Vincristine—colon cancer	0.000746	0.00158	CcSEcCtD
Oxybutynin—Syncope—Capecitabine—colon cancer	0.000744	0.00158	CcSEcCtD
Oxybutynin—Palpitations—Capecitabine—colon cancer	0.000733	0.00156	CcSEcCtD
Oxybutynin—Loss of consciousness—Capecitabine—colon cancer	0.000729	0.00155	CcSEcCtD
Oxybutynin—Asthenia—Irinotecan—colon cancer	0.000726	0.00154	CcSEcCtD
Oxybutynin—Cough—Capecitabine—colon cancer	0.000724	0.00154	CcSEcCtD
Oxybutynin—Hypertension—Capecitabine—colon cancer	0.000717	0.00152	CcSEcCtD
Oxybutynin—Hypersensitivity—Fluorouracil—colon cancer	0.000714	0.00151	CcSEcCtD
Oxybutynin—Diarrhoea—Vincristine—colon cancer	0.000711	0.00151	CcSEcCtD
Oxybutynin—Arthralgia—Capecitabine—colon cancer	0.000707	0.0015	CcSEcCtD
Oxybutynin—Chest pain—Capecitabine—colon cancer	0.000707	0.0015	CcSEcCtD
Oxybutynin—Pharyngitis—Methotrexate—colon cancer	0.000704	0.00149	CcSEcCtD
Oxybutynin—Anxiety—Capecitabine—colon cancer	0.000704	0.00149	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000702	0.00149	CcSEcCtD
Oxybutynin—Urinary tract disorder—Methotrexate—colon cancer	0.000701	0.00149	CcSEcCtD
Oxybutynin—Discomfort—Capecitabine—colon cancer	0.000698	0.00148	CcSEcCtD
Oxybutynin—Urethral disorder—Methotrexate—colon cancer	0.000696	0.00148	CcSEcCtD
Oxybutynin—Diarrhoea—Irinotecan—colon cancer	0.000692	0.00147	CcSEcCtD
Oxybutynin—Dry mouth—Capecitabine—colon cancer	0.000691	0.00147	CcSEcCtD
Oxybutynin—Dizziness—Vincristine—colon cancer	0.000687	0.00146	CcSEcCtD
Oxybutynin—Pruritus—Fluorouracil—colon cancer	0.000686	0.00145	CcSEcCtD
Oxybutynin—Visual impairment—Methotrexate—colon cancer	0.000684	0.00145	CcSEcCtD
Oxybutynin—Confusional state—Capecitabine—colon cancer	0.000683	0.00145	CcSEcCtD
Oxybutynin—Oedema—Capecitabine—colon cancer	0.000677	0.00144	CcSEcCtD
Oxybutynin—Infection—Capecitabine—colon cancer	0.000673	0.00143	CcSEcCtD
Oxybutynin—Dizziness—Irinotecan—colon cancer	0.000669	0.00142	CcSEcCtD
Oxybutynin—Shock—Capecitabine—colon cancer	0.000666	0.00141	CcSEcCtD
Oxybutynin—Nervous system disorder—Capecitabine—colon cancer	0.000664	0.00141	CcSEcCtD
Oxybutynin—Eye disorder—Methotrexate—colon cancer	0.000663	0.00141	CcSEcCtD
Oxybutynin—Diarrhoea—Fluorouracil—colon cancer	0.000663	0.00141	CcSEcCtD
Oxybutynin—Tinnitus—Methotrexate—colon cancer	0.000662	0.0014	CcSEcCtD
Oxybutynin—Tachycardia—Capecitabine—colon cancer	0.000661	0.0014	CcSEcCtD
Oxybutynin—Vomiting—Vincristine—colon cancer	0.000661	0.0014	CcSEcCtD
Oxybutynin—Cardiac disorder—Methotrexate—colon cancer	0.000659	0.0014	CcSEcCtD
Oxybutynin—Skin disorder—Capecitabine—colon cancer	0.000658	0.0014	CcSEcCtD
Oxybutynin—Rash—Vincristine—colon cancer	0.000655	0.00139	CcSEcCtD
Oxybutynin—Dermatitis—Vincristine—colon cancer	0.000655	0.00139	CcSEcCtD
Oxybutynin—Headache—Vincristine—colon cancer	0.000651	0.00138	CcSEcCtD
Oxybutynin—Anorexia—Capecitabine—colon cancer	0.000646	0.00137	CcSEcCtD
Oxybutynin—Angiopathy—Methotrexate—colon cancer	0.000644	0.00137	CcSEcCtD
Oxybutynin—Vomiting—Irinotecan—colon cancer	0.000644	0.00136	CcSEcCtD
Oxybutynin—Dizziness—Fluorouracil—colon cancer	0.000641	0.00136	CcSEcCtD
Oxybutynin—Mediastinal disorder—Methotrexate—colon cancer	0.00064	0.00136	CcSEcCtD
Oxybutynin—Rash—Irinotecan—colon cancer	0.000638	0.00135	CcSEcCtD
Oxybutynin—Dermatitis—Irinotecan—colon cancer	0.000638	0.00135	CcSEcCtD
Oxybutynin—Headache—Irinotecan—colon cancer	0.000634	0.00134	CcSEcCtD
Oxybutynin—Hypotension—Capecitabine—colon cancer	0.000633	0.00134	CcSEcCtD
Oxybutynin—Mental disorder—Methotrexate—colon cancer	0.000622	0.00132	CcSEcCtD
Oxybutynin—Erythema—Methotrexate—colon cancer	0.000618	0.00131	CcSEcCtD
Oxybutynin—Malnutrition—Methotrexate—colon cancer	0.000618	0.00131	CcSEcCtD
Oxybutynin—Nausea—Vincristine—colon cancer	0.000617	0.00131	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000617	0.00131	CcSEcCtD
Oxybutynin—Vomiting—Fluorouracil—colon cancer	0.000616	0.00131	CcSEcCtD
Oxybutynin—Insomnia—Capecitabine—colon cancer	0.000613	0.0013	CcSEcCtD
Oxybutynin—Rash—Fluorouracil—colon cancer	0.000611	0.0013	CcSEcCtD
Oxybutynin—Dermatitis—Fluorouracil—colon cancer	0.000611	0.0013	CcSEcCtD
Oxybutynin—Paraesthesia—Capecitabine—colon cancer	0.000608	0.00129	CcSEcCtD
Oxybutynin—Headache—Fluorouracil—colon cancer	0.000607	0.00129	CcSEcCtD
Oxybutynin—Dysgeusia—Methotrexate—colon cancer	0.000605	0.00128	CcSEcCtD
Oxybutynin—Nausea—Irinotecan—colon cancer	0.000601	0.00128	CcSEcCtD
Oxybutynin—Back pain—Methotrexate—colon cancer	0.000598	0.00127	CcSEcCtD
Oxybutynin—Dyspepsia—Capecitabine—colon cancer	0.000596	0.00126	CcSEcCtD
Oxybutynin—Decreased appetite—Capecitabine—colon cancer	0.000589	0.00125	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000585	0.00124	CcSEcCtD
Oxybutynin—Fatigue—Capecitabine—colon cancer	0.000584	0.00124	CcSEcCtD
Oxybutynin—Vision blurred—Methotrexate—colon cancer	0.000582	0.00124	CcSEcCtD
Oxybutynin—Pain—Capecitabine—colon cancer	0.000579	0.00123	CcSEcCtD
Oxybutynin—Constipation—Capecitabine—colon cancer	0.000579	0.00123	CcSEcCtD
Oxybutynin—Nausea—Fluorouracil—colon cancer	0.000576	0.00122	CcSEcCtD
Oxybutynin—Ill-defined disorder—Methotrexate—colon cancer	0.000573	0.00122	CcSEcCtD
Oxybutynin—Feeling abnormal—Capecitabine—colon cancer	0.000558	0.00118	CcSEcCtD
Oxybutynin—Malaise—Methotrexate—colon cancer	0.000557	0.00118	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Capecitabine—colon cancer	0.000554	0.00117	CcSEcCtD
Oxybutynin—Cough—Methotrexate—colon cancer	0.000539	0.00114	CcSEcCtD
Oxybutynin—Urticaria—Capecitabine—colon cancer	0.000538	0.00114	CcSEcCtD
Oxybutynin—Abdominal pain—Capecitabine—colon cancer	0.000535	0.00114	CcSEcCtD
Oxybutynin—Convulsion—Methotrexate—colon cancer	0.000535	0.00114	CcSEcCtD
Oxybutynin—Chest pain—Methotrexate—colon cancer	0.000526	0.00112	CcSEcCtD
Oxybutynin—Arthralgia—Methotrexate—colon cancer	0.000526	0.00112	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000522	0.00111	CcSEcCtD
Oxybutynin—Discomfort—Methotrexate—colon cancer	0.00052	0.0011	CcSEcCtD
Oxybutynin—Confusional state—Methotrexate—colon cancer	0.000508	0.00108	CcSEcCtD
Oxybutynin—Anaphylactic shock—Methotrexate—colon cancer	0.000504	0.00107	CcSEcCtD
Oxybutynin—Infection—Methotrexate—colon cancer	0.000501	0.00106	CcSEcCtD
Oxybutynin—Hypersensitivity—Capecitabine—colon cancer	0.000499	0.00106	CcSEcCtD
Oxybutynin—Nervous system disorder—Methotrexate—colon cancer	0.000495	0.00105	CcSEcCtD
Oxybutynin—Skin disorder—Methotrexate—colon cancer	0.00049	0.00104	CcSEcCtD
Oxybutynin—Asthenia—Capecitabine—colon cancer	0.000486	0.00103	CcSEcCtD
Oxybutynin—Anorexia—Methotrexate—colon cancer	0.000481	0.00102	CcSEcCtD
Oxybutynin—Pruritus—Capecitabine—colon cancer	0.000479	0.00102	CcSEcCtD
Oxybutynin—Hypotension—Methotrexate—colon cancer	0.000471	0.000999	CcSEcCtD
Oxybutynin—Diarrhoea—Capecitabine—colon cancer	0.000463	0.000983	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000459	0.000974	CcSEcCtD
Oxybutynin—Insomnia—Methotrexate—colon cancer	0.000456	0.000967	CcSEcCtD
Oxybutynin—Paraesthesia—Methotrexate—colon cancer	0.000453	0.00096	CcSEcCtD
Oxybutynin—Somnolence—Methotrexate—colon cancer	0.000448	0.000951	CcSEcCtD
Oxybutynin—Dizziness—Capecitabine—colon cancer	0.000448	0.00095	CcSEcCtD
Oxybutynin—Dyspepsia—Methotrexate—colon cancer	0.000444	0.000942	CcSEcCtD
Oxybutynin—Decreased appetite—Methotrexate—colon cancer	0.000438	0.00093	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000435	0.000923	CcSEcCtD
Oxybutynin—Fatigue—Methotrexate—colon cancer	0.000435	0.000922	CcSEcCtD
Oxybutynin—Pain—Methotrexate—colon cancer	0.000431	0.000915	CcSEcCtD
Oxybutynin—Vomiting—Capecitabine—colon cancer	0.000431	0.000914	CcSEcCtD
Oxybutynin—Rash—Capecitabine—colon cancer	0.000427	0.000906	CcSEcCtD
Oxybutynin—Dermatitis—Capecitabine—colon cancer	0.000427	0.000905	CcSEcCtD
Oxybutynin—Headache—Capecitabine—colon cancer	0.000424	0.0009	CcSEcCtD
Oxybutynin—Feeling abnormal—Methotrexate—colon cancer	0.000416	0.000881	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Methotrexate—colon cancer	0.000412	0.000875	CcSEcCtD
Oxybutynin—Nausea—Capecitabine—colon cancer	0.000402	0.000853	CcSEcCtD
Oxybutynin—Urticaria—Methotrexate—colon cancer	0.000401	0.00085	CcSEcCtD
Oxybutynin—Abdominal pain—Methotrexate—colon cancer	0.000399	0.000846	CcSEcCtD
Oxybutynin—Hypersensitivity—Methotrexate—colon cancer	0.000372	0.000788	CcSEcCtD
Oxybutynin—Asthenia—Methotrexate—colon cancer	0.000362	0.000767	CcSEcCtD
Oxybutynin—Pruritus—Methotrexate—colon cancer	0.000357	0.000757	CcSEcCtD
Oxybutynin—Diarrhoea—Methotrexate—colon cancer	0.000345	0.000732	CcSEcCtD
Oxybutynin—Dizziness—Methotrexate—colon cancer	0.000333	0.000707	CcSEcCtD
Oxybutynin—Vomiting—Methotrexate—colon cancer	0.000321	0.00068	CcSEcCtD
Oxybutynin—Rash—Methotrexate—colon cancer	0.000318	0.000674	CcSEcCtD
Oxybutynin—Dermatitis—Methotrexate—colon cancer	0.000318	0.000674	CcSEcCtD
Oxybutynin—Headache—Methotrexate—colon cancer	0.000316	0.00067	CcSEcCtD
Oxybutynin—Nausea—Methotrexate—colon cancer	0.0003	0.000635	CcSEcCtD
